168 related articles for article (PubMed ID: 2844633)
1. [HCG and SP-1 as markers in trophoblast tumors. The HCG/SP-1 ratio].
Than GN; Tatra G; Csaba IF; Szabo DG; Bohn H
Gynakol Rundsch; 1988; 28(3):157-65. PubMed ID: 2844633
[No Abstract] [Full Text] [Related]
2. The diagnostic value of circulating trophoblast-specific beta 1-glycoprotein (TSG) in cancer patients.
Tatarinov YS
Br J Cancer; 1980 May; 41(5):821-4. PubMed ID: 6252917
[No Abstract] [Full Text] [Related]
3. Human chorionic gonadotropin assays and their uses.
Tyrey L
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
[TBL] [Abstract][Full Text] [Related]
4. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
5. [Gestational trophoblast tumors--rare, but important in general practice].
Ebeling K; Schönborn I; Johannsmeyer D
Z Arztl Fortbild (Jena); 1994 Oct; 88(10):773-8. PubMed ID: 7529957
[No Abstract] [Full Text] [Related]
6. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of patients with trophoblastic tumor in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
ten Kate-Booij MJ; Verheyen RH; Schijf CP
Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2393-4. PubMed ID: 7501086
[No Abstract] [Full Text] [Related]
8. Nonmetastatic gestational trophoblastic neoplasms.
Schlaerth JB
Gynecol Oncol; 1993 Feb; 48(2):137. PubMed ID: 8381373
[No Abstract] [Full Text] [Related]
9. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
10. Elevated hCG and a high proportion of hCGbeta in serum preceding the diagnosis of trophoblastic disease by seven months.
Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
BJOG; 2002 May; 109(5):589-90. PubMed ID: 12066956
[No Abstract] [Full Text] [Related]
11. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
12. [Difficulties and biases of interpretation in cases of the trophoblast disease].
Kichukova D; Piperkov T; Peev B
Akush Ginekol (Sofiia); 2004; 43(3):50-3. PubMed ID: 15341260
[TBL] [Abstract][Full Text] [Related]
13. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
14. Trophoblastic disease: Analytical problems associated with HCG assay.
Barth JH
BMJ; 2008 Oct; 337():a2076. PubMed ID: 18852174
[No Abstract] [Full Text] [Related]
15. Evolving concepts of molar pregnancy.
Berkowitz RS; Goldstein DP; Bernstein MR
J Reprod Med; 1991 Jan; 36(1):40-4. PubMed ID: 1848899
[TBL] [Abstract][Full Text] [Related]
16. New criteria for the diagnosis of gestational trophoblastic disease.
Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
[TBL] [Abstract][Full Text] [Related]
17. Elevated HCG outside of pregnancy--diagnostic considerations and laboratory evaluation.
Olsen TG; Barnes AA; King JA
Obstet Gynecol Surv; 2007 Oct; 62(10):669-74; quiz 691. PubMed ID: 17868485
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of HCG and hCG beta determinations.
Mann K; Saller B; Hoermann R
Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Feb; 48(2):139-47. PubMed ID: 8381374
[TBL] [Abstract][Full Text] [Related]
20. HCG--choosing the best assay to monitor gestational trophoblastic disease and other germ cell tumours.
Evans BD; Harvey VJ; Knox BS; Duff G
N Z Med J; 1993 Jun; 106(958):261. PubMed ID: 8392672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
